Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Peripherally Acting Anti-Obesity Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Prescription Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peripherally Acting Anti-Obesity Drug include Novo Nordisk A/S, Pfizer Inc., Boehringer Ingelheim International GmbH, KVK Tech Inc., Gelesis Holdings, Vivus LLC., Currax Pharmaceuticals LLC, GlaxoSmithKline plc and CHEPLAPHARM Arzneimittel GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Peripherally Acting Anti-Obesity Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripherally Acting Anti-Obesity Drug. This report contains market size and forecasts of Peripherally Acting Anti-Obesity Drug in global, including the following market information:
Global Peripherally Acting Anti-Obesity Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Peripherally Acting Anti-Obesity Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Peripherally Acting Anti-Obesity Drug companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Peripherally Acting Anti-Obesity Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peripherally Acting Anti-Obesity Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Peripherally Acting Anti-Obesity Drug Market Segment Percentages, by Type, 2022 (%)
Prescription Drugs
Non-prescription Drugs
Global Peripherally Acting Anti-Obesity Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Peripherally Acting Anti-Obesity Drug Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Peripherally Acting Anti-Obesity Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Peripherally Acting Anti-Obesity Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peripherally Acting Anti-Obesity Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peripherally Acting Anti-Obesity Drug revenues share in global market, 2022 (%)
Key companies Peripherally Acting Anti-Obesity Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Peripherally Acting Anti-Obesity Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk A/S
Pfizer Inc.
Boehringer Ingelheim International GmbH
KVK Tech Inc.
Gelesis Holdings
Vivus LLC.
Currax Pharmaceuticals LLC
GlaxoSmithKline plc
CHEPLAPHARM Arzneimittel GmbH
Rhythm Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peripherally Acting Anti-Obesity Drug, market overview.
Chapter 2: Global Peripherally Acting Anti-Obesity Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Peripherally Acting Anti-Obesity Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peripherally Acting Anti-Obesity Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peripherally Acting Anti-Obesity Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Peripherally Acting Anti-Obesity Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Peripherally Acting Anti-Obesity Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Peripherally Acting Anti-Obesity Drug Overall Market Size
2.1 Global Peripherally Acting Anti-Obesity Drug Market Size: 2022 VS 2029
2.2 Global Peripherally Acting Anti-Obesity Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Peripherally Acting Anti-Obesity Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Peripherally Acting Anti-Obesity Drug Players in Global Market
3.2 Top Global Peripherally Acting Anti-Obesity Drug Companies Ranked by Revenue
3.3 Global Peripherally Acting Anti-Obesity Drug Revenue by Companies
3.4 Global Peripherally Acting Anti-Obesity Drug Sales by Companies
3.5 Global Peripherally Acting Anti-Obesity Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Peripherally Acting Anti-Obesity Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Peripherally Acting Anti-Obesity Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Peripherally Acting Anti-Obesity Drug Players in Global Market
3.8.1 List of Global Tier 1 Peripherally Acting Anti-Obesity Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Peripherally Acting Anti-Obesity Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Peripherally Acting Anti-Obesity Drug Market Size Markets, 2022 & 2029
4.1.2 Prescription Drugs
4.1.3 Non-prescription Drugs
4.2 By Type - Global Peripherally Acting Anti-Obesity Drug Revenue & Forecasts
4.2.1 By Type - Global Peripherally Acting Anti-Obesity Drug Revenue, 2018-2023
4.2.2 By Type - Global Peripherally Acting Anti-Obesity Drug Revenue, 2024-2029
4.2.3 By Type - Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2018-2029
4.3 By Type - Global Peripherally Acting Anti-Obesity Drug Sales & Forecasts
4.3.1 By Type - Global Peripherally Acting Anti-Obesity Drug Sales, 2018-2023
4.3.2 By Type - Global Peripherally Acting Anti-Obesity Drug Sales, 2024-2029
4.3.3 By Type - Global Peripherally Acting Anti-Obesity Drug Sales Market Share, 2018-2029
4.4 By Type - Global Peripherally Acting Anti-Obesity Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Peripherally Acting Anti-Obesity Drug Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Peripherally Acting Anti-Obesity Drug Revenue & Forecasts
5.2.1 By Application - Global Peripherally Acting Anti-Obesity Drug Revenue, 2018-2023
5.2.2 By Application - Global Peripherally Acting Anti-Obesity Drug Revenue, 2024-2029
5.2.3 By Application - Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2018-2029
5.3 By Application - Global Peripherally Acting Anti-Obesity Drug Sales & Forecasts
5.3.1 By Application - Global Peripherally Acting Anti-Obesity Drug Sales, 2018-2023
5.3.2 By Application - Global Peripherally Acting Anti-Obesity Drug Sales, 2024-2029
5.3.3 By Application - Global Peripherally Acting Anti-Obesity Drug Sales Market Share, 2018-2029
5.4 By Application - Global Peripherally Acting Anti-Obesity Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Peripherally Acting Anti-Obesity Drug Market Size, 2022 & 2029
6.2 By Region - Global Peripherally Acting Anti-Obesity Drug Revenue & Forecasts
6.2.1 By Region - Global Peripherally Acting Anti-Obesity Drug Revenue, 2018-2023
6.2.2 By Region - Global Peripherally Acting Anti-Obesity Drug Revenue, 2024-2029
6.2.3 By Region - Global Peripherally Acting Anti-Obesity Drug Revenue Market Share, 2018-2029
6.3 By Region - Global Peripherally Acting Anti-Obesity Drug Sales & Forecasts
6.3.1 By Region - Global Peripherally Acting Anti-Obesity Drug Sales, 2018-2023
6.3.2 By Region - Global Peripherally Acting Anti-Obesity Drug Sales, 2024-2029
6.3.3 By Region - Global Peripherally Acting Anti-Obesity Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Peripherally Acting Anti-Obesity Drug Revenue, 2018-2029
6.4.2 By Country - North America Peripherally Acting Anti-Obesity Drug Sales, 2018-2029
6.4.3 US Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.4.4 Canada Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.4.5 Mexico Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Peripherally Acting Anti-Obesity Drug Revenue, 2018-2029
6.5.2 By Country - Europe Peripherally Acting Anti-Obesity Drug Sales, 2018-2029
6.5.3 Germany Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.4 France Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.5 U.K. Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.6 Italy Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.7 Russia Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.8 Nordic Countries Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.5.9 Benelux Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Peripherally Acting Anti-Obesity Drug Revenue, 2018-2029
6.6.2 By Region - Asia Peripherally Acting Anti-Obesity Drug Sales, 2018-2029
6.6.3 China Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.6.4 Japan Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.6.5 South Korea Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.6.6 Southeast Asia Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.6.7 India Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Peripherally Acting Anti-Obesity Drug Revenue, 2018-2029
6.7.2 By Country - South America Peripherally Acting Anti-Obesity Drug Sales, 2018-2029
6.7.3 Brazil Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.7.4 Argentina Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Peripherally Acting Anti-Obesity Drug Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Peripherally Acting Anti-Obesity Drug Sales, 2018-2029
6.8.3 Turkey Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.8.4 Israel Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
6.8.6 UAE Peripherally Acting Anti-Obesity Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novo Nordisk A/S
7.1.1 Novo Nordisk A/S Company Summary
7.1.2 Novo Nordisk A/S Business Overview
7.1.3 Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.1.4 Novo Nordisk A/S Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.1.5 Novo Nordisk A/S Key News & Latest Developments
7.2 Pfizer Inc.
7.2.1 Pfizer Inc. Company Summary
7.2.2 Pfizer Inc. Business Overview
7.2.3 Pfizer Inc. Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.2.4 Pfizer Inc. Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Inc. Key News & Latest Developments
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Company Summary
7.3.2 Boehringer Ingelheim International GmbH Business Overview
7.3.3 Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.3.4 Boehringer Ingelheim International GmbH Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.3.5 Boehringer Ingelheim International GmbH Key News & Latest Developments
7.4 KVK Tech Inc.
7.4.1 KVK Tech Inc. Company Summary
7.4.2 KVK Tech Inc. Business Overview
7.4.3 KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.4.4 KVK Tech Inc. Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.4.5 KVK Tech Inc. Key News & Latest Developments
7.5 Gelesis Holdings
7.5.1 Gelesis Holdings Company Summary
7.5.2 Gelesis Holdings Business Overview
7.5.3 Gelesis Holdings Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.5.4 Gelesis Holdings Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.5.5 Gelesis Holdings Key News & Latest Developments
7.6 Vivus LLC.
7.6.1 Vivus LLC. Company Summary
7.6.2 Vivus LLC. Business Overview
7.6.3 Vivus LLC. Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.6.4 Vivus LLC. Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.6.5 Vivus LLC. Key News & Latest Developments
7.7 Currax Pharmaceuticals LLC
7.7.1 Currax Pharmaceuticals LLC Company Summary
7.7.2 Currax Pharmaceuticals LLC Business Overview
7.7.3 Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.7.4 Currax Pharmaceuticals LLC Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.7.5 Currax Pharmaceuticals LLC Key News & Latest Developments
7.8 GlaxoSmithKline plc
7.8.1 GlaxoSmithKline plc Company Summary
7.8.2 GlaxoSmithKline plc Business Overview
7.8.3 GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.8.4 GlaxoSmithKline plc Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.8.5 GlaxoSmithKline plc Key News & Latest Developments
7.9 CHEPLAPHARM Arzneimittel GmbH
7.9.1 CHEPLAPHARM Arzneimittel GmbH Company Summary
7.9.2 CHEPLAPHARM Arzneimittel GmbH Business Overview
7.9.3 CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.9.4 CHEPLAPHARM Arzneimittel GmbH Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.9.5 CHEPLAPHARM Arzneimittel GmbH Key News & Latest Developments
7.10 Rhythm Pharmaceuticals
7.10.1 Rhythm Pharmaceuticals Company Summary
7.10.2 Rhythm Pharmaceuticals Business Overview
7.10.3 Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Major Product Offerings
7.10.4 Rhythm Pharmaceuticals Peripherally Acting Anti-Obesity Drug Sales and Revenue in Global (2018-2023)
7.10.5 Rhythm Pharmaceuticals Key News & Latest Developments
8 Global Peripherally Acting Anti-Obesity Drug Production Capacity, Analysis
8.1 Global Peripherally Acting Anti-Obesity Drug Production Capacity, 2018-2029
8.2 Peripherally Acting Anti-Obesity Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Peripherally Acting Anti-Obesity Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Peripherally Acting Anti-Obesity Drug Supply Chain Analysis
10.1 Peripherally Acting Anti-Obesity Drug Industry Value Chain
10.2 Peripherally Acting Anti-Obesity Drug Upstream Market
10.3 Peripherally Acting Anti-Obesity Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Peripherally Acting Anti-Obesity Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
